CME: Ocular surface disease (OSD): diagnostic, management, and clinical considerations in dry eye
ACCREDITATION EXPIRED: June 16, 2019
Activity Description / Statement of Need:
In this online CME self-learning program:
Dry eye disease (“dry eye”), also referred to as ocular surface disease and keratoconjunctivitis sicca, is a condition with a diverse group of etiologies and clinical presentations. Common symptoms include discomfort or pain, visual disturbance, and tear film instability. Compared with those without the condition, patients with dry eye experience higher rates of lost of work productivity, impaired of daily activities, medical visits, and sleep and mood disorders, and worse emotion well-being and overall quality of life. Although dry eye prevalence varies based on a variety of patient factors, estimates place the prevalence of dry eye as high as 19% of the adult population and more than 34% of the elderly population.
Due to the widespread impact of dry eye, it has been termed a “modern epidemic,” yet current clinical practice in terms of understanding, diagnosing, and managing dry eye is suboptimal, representing a potential gap in care. Dry eye is both underdiagnosed and undertreated.
Agenda
- Faculty introduction, disclosures
- Is dry eye disease (DED) worth the effort?
- Core pathogenesis
- Why Omega 3?
- DREAM clinical trial
- Exploratory endpoints
- Can DED be diagnosed in 30 seconds?
- On the horizon for DED
- Summary
Target Audience:
The following healthcare professionals: ophthalmology and optometry; physician assistants, nurse practitioners, nurses, and pharmacists who practice or are interested in ophthalmology; and any other healthcare professionals with an interest in or who clinically encounter patients with dry eye.
This program is supported by an educational grant from Allergan.
Release Date: June 16, 2017 -- Expiration Date: June 16, 2019
Faculty: Penny Asbell, MD
Agenda
Learning Objectives
By the end of the session the participant will be able to:
- Discuss the causes, symptoms, and types of dry eye or ocular surface disease, emphasizing the pathophysiology that impacts treatment decisions
- Describe the clinical implications of dry eye on contact lens or surgical success, and apply this knowledge in patient cases when discussing expectations with patients
- Utilize patient history, ocular examination, and tear quantity tests to accurately diagnose ocular surface disease, with an emphasis on the importance of early diagnosis
- Compare available and emerging treatments for ocular surface disease based on mechanisms of action and efficacy, with a focus on individualizing treatments to improve patient outcomes
Accreditation
ACCREDITATION FOR THIS COURSE HAS EXPIRED. YOU MAY VIEW THE PROGRAM, BUT CME / CE IS NO LONGER AVAILABLE AND NO CERTIFICATE WILL BE ISSUED.
Faculty Disclosure and Resolution of COI
As a provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of ScientiaCME to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved thru content review ScientiaCME.
Faculty Disclosure: Dr. Penny Asbell, MD, MBA, FARVO Icahn School of Medicine, New York, New York has received research support and/or is a consultant for: Allergan, Alcon, B&L, and MC2
Disclosures of Educational Planners: Charles Turck, PharmD, BCPS, BCCCP has no relevant conflicts of interest to disclose.
Commercial Support Disclosure: This program is supported by an educational grant from Allergan.
Instructions
- Read the learning objectives above
- Take the Pre-Test (optional). Completion of the pre-test will help us evaluate the knowledge gained by participating in this CME activity.
- View the online activity. You may view this is in more than one session, and may pause or repeat any portion of the presentation if you need to.
- Minimum participation threshold: Take the post-test. A score of 60% or higher is required to pass and proceed to the activity evaluation.
- Complete the activity evaluation and CME registration. A CE certificate will be emailed to you immediately.
System Requirements
Windows 7 or above
Internet Explorer 8
*Adobe Acrobat Reader
Mac OS 10.2.8
Safari or Chrome or Firefox
*Adobe Acrobat Reader
Internet Explorer is not supported on the Macintosh
*Required to view Printable PDF Version
Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.
Additional Courses That Are Related To This Activity
Glaucoma: therapeutic updates, best practices, and barriers to effective care
Dry Eye Disease: Therapeutic Updates and Optimizing Treatment